Food and Drug Administration

Joint Meeting of the Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee

February 18, 2005


Interpretation of Observed Differences in the Frequency of Events When the Number of Events is Small, Dr. Milton Packer, MD, FDA (HTM) (PPT)

Clinical Trial Design and Patient Safety: Future Directions for COX-2 Selective NSAIDs, Dr. Robert Temple, MD, FDA (HTM) (PPT)

Issues in Projecting Increased Risk of Cardiovascular Events to the Exposed Population, Dr. Robert O'Neill, PhD, FDA (HTM) (PPT)

Options for Action, Dr. Anne Trontell, MD, FDA (HTM) (PPT)

Reason We Are Here, Dr. Sharon Hertz, MD, FDA (HTM) (PPT)

Questions (HTM) (PPT)